SWI/SNF complexes shape 3D chromatin architecture through CTCF and cohesin
. However, a unifying mechanism that explains their widespread disruption remains unclear. Here we disrupted BAF function through pharmacological inhibition and ARID1A deletion across various mammalian cell types and tissues and observed a conserved chromatin response: increased accessibility at CTCF-binding sites. ARID1A LOF alone was sufficient to drive these changes, which demonstrates that canonical BAF (cBAF) disruption is the key driver of CTCF gain. Genomic profiling showed increased CTCF and SMC3 occupancy, which reveals an antagonistic relationship between cBAF and CTCF-cohesin complexes. Furthermore, cBAF loss restructured 3D genome organization, which led to a strengthening of topologically associating domain boundaries and subdivision of large domains into smaller insulated structures. Long-range enhancer-promoter loops were replaced by shorter, promoter-proximal loops anchored at CTCF-enriched sites. To determine how CTCF function is enabled following cBAF loss, we profiled CTCF-interacting cofactors and found that CTCF binds directly to fully assembled PBAF. After cBAF depletion, PBAF was recruited to sites of increased CTCF occupancy, which demonstrates that there is an antagonistic switch between SWI/SNF subcomplexes. In vivo, conditional Arid1a deletion in primary mouse cells resulted in the expansion of a highly proliferative population marked by elevated accessibility at CTCF sites. This phenotype was fully reversed by either Ctcf or Pbrm1 deletion, which establishes that cBAF and the activity of CTCF and PBAF have contrasting roles.
Authors
- Cem Meydan (ORCID: https://orcid.org/0000-0002-0663-6216)
- Sravya Tumuluru (ORCID: https://orcid.org/0009-0001-2091-821X)
- Darko Barišić (ORCID: https://orcid.org/0000-0001-7007-9138)
- Martín A. Rivas (ORCID: https://orcid.org/0000-0002-9603-6897)
- Ioanna Tsialta (ORCID: https://orcid.org/0009-0004-5666-775X)
- Effie Apostolou (ORCID: https://orcid.org/0000-0002-8111-0863)
- Ari M. Melnick (ORCID: https://orcid.org/0000-0002-8074-2287)
- Kojo S.J. Elenitoba‐Johnson (ORCID: https://orcid.org/0000-0002-1082-1545)
- José Luis Marín‐Rubio (ORCID: https://orcid.org/0000-0002-7682-0190)
- Ceyda Durmaz (ORCID: https://orcid.org/0000-0002-7050-3653)
- Rui Wu (ORCID: https://orcid.org/0000-0002-4956-470X)
- Viviana I. Risca (ORCID: https://orcid.org/0000-0003-2670-8704)
- Sonia M. Debek (ORCID: https://orcid.org/0000-0001-9267-603X)
- Matthias Stadtfeld (ORCID: https://orcid.org/0000-0002-5852-9906)
- Laurianne Scourzic (ORCID: https://orcid.org/0000-0003-2875-1642)
- Arnold Ou (ORCID: https://orcid.org/0000-0002-3903-0018)
- Constance Maurer (ORCID: https://orcid.org/0000-0002-9720-0118)
- Alejandra Laguillo-Diego (ORCID: https://orcid.org/0000-0003-2724-7890)
- Christopher R. Chin (ORCID: https://orcid.org/0000-0002-2140-3197)
- Christopher E. Mason (ORCID: https://orcid.org/0000-0002-1850-1642)
- Matt Teater
- Benedikt Pelzer
- Brian Darsow
- Jiali Yu
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Miami (US)
- Queen Mary University of London (GB)
- Cornell University (US)
- Josep Carreras Leukaemia Research Institute (ES)
- Sylvester Comprehensive Cancer Center (US)
- Weill Cornell Medicine (US)
- Barts Cancer Institute (GB)
- Weill Cornell Medical Center (US)
- Rockefeller University (US)
Publication Details
- Journal
- Nature
- Published
- 2026-10-28
- DOI
- https://doi.org/10.1038/s41586-026-11197-w
- Citations
- 1
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.07